Full Breakdown
Coco Gauff Calls for Nuance on WTA Gene-Testing Policy
8/8/2026, 8:01:03 AM
Core Event: WTA Mandates One-Time SRY Gene Test
The Women’s Tennis Association (WTA) announced a new eligibility rule that requires every player to undergo a one-time genetic screen for the SRY gene—a DNA segment on the Y chromosome that initiates male-typical development. The test can be done via cheek swab, blood sample, or saliva. Players who test negative remain eligible; a positive result triggers medical assessment, with exceptions for athletes who have Complete Androgen Insensitivity Syndrome or other qualifying developmental disorders. The policy, released on July 21, will be enforced beginning in 2026 and is a prerequisite for participation in the 2028 Los Angeles Olympics. No openly transgender women are currently active on the WTA Tour.
Background & Context
The WTA’s revision follows a broader shift in international sport. The International Olympic Committee reinstated SRY-gene screening for all women’s events ahead of the 2028 Games, and World Athletics and several other federations already employ similar testing. Previously, the WTA allowed transgender and non-binary athletes to compete provided their blood testosterone stayed below 2.5 nmol/L for a set period.
Data & Statistics
- Test target: SRY gene (presence indicates typical male development).
- Methods: Cheek swab, blood draw, or saliva sample.
- Eligibility outcome: Negative -> immediate eligibility; Positive -> medical review, possible ineligibility unless a qualifying disorder is documented.
- Exceptions: Complete Androgen Insensitivity Syndrome or other gonadal development disorders.
- Current roster: No known transgender women competing on the tour.
Official Statements & Responses
World No. 2 Elena Rybakina said she would comply with testing and did not consider it unnecessary.
World No. 3 Jessica Pegula, a member of the WTA Players’ Council, noted that the organization had provided education and briefing materials before implementation and expects testing to begin at the Cincinnati Open.
American star Coco Gauff acknowledged the reasoning behind the policy while expressing concern that the debate has been weaponized against transgender people. She also criticized the timing of the announcement, noting that many players learned of the rule only after the public release.
Criticism & Opposition
Human-rights experts and activist groups have criticized mandatory genetic screening as an infringement on privacy and dignity, though the WTA maintains the measure is sport-specific.
Verbatim Quotes
- “I understand the reasoning behind it. I do think that this kind of conversation has created a lot of animosity towards the trans community, which I’m not really a big fan of,” — Coco Gauff
- “I think it’s really important to keep the fairness in our tour,” — Aryna Sabalenka
- “If there is a change in the SRY gene so it does not function as usual, then a person can fail to develop testes and be biologically female,” — Andrew Sinclair, scientist
What’s Next
Testing is slated to start at the Cincinnati Open and will be required for all players who wish to compete at the 2028 Los Angeles Olympics. The WTA has indicated that athletes may appeal eligibility decisions in state or federal court in Saint Petersburg, Florida, or before the Court of Arbitration for Sport in Switzerland.
